Nanjing Xiyuxun Technology XYX
Retatrutide
Finnrick tested 2 samples of Retatrutide (GLP-1, GIP, and GCGR agonist) from Nanjing Xiyuxun Technology XYX between 20 May 2025 and 23 Oct 2025. Test scores average over 4, no score below 3, and at least 2 tests warrant a tentative Finnrick Rating of D (Poor).
Finnrick Rating™
Tentative Rating
Nanjing Xiyuxun Technology XYX
Retatrutide
Tested 2 Samples
Last test 23 Oct 2025
Take Action
Researcher
Request Full Data Access to the Finnrick database of peptide tests.
Free peptide testing
Mail in a sample (US only) to get confidence for the specific vials you have, and contribute to identifying unsafe supply chains, so other people can avoid risky and costly mistakes.
Other Retatrutide tests from top-rated vendors:
All Retatrutide tests from Nanjing Xiyuxun Technology XYX
Samples are tested in commercial labs
Tests Count
2
Scores
AVGMINMAX
Last
23 Oct 2025
First
20 May 2025
| Quantity | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Test Date | Certificate | Test Score | Label | Tested | Difference | Purity | Batch ID | Container | Tested At | Sent By |
| 23 Oct 2025 | View | 10mg | 7.850mg | -21.5% | 99.56% | (no batch ID) | White Label / Silver Crimp / Clear Blue Cap | Lab E | Public | |
| 20 May 2025 | View | 30mg | 25.600mg | -14.7% | 99.94% | (no batch ID) | No Label / Silver Crimp / Violet Cap | Lab | Public | |